Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2005(18): 3159-3166
DOI: 10.1055/s-2005-918426
DOI: 10.1055/s-2005-918426
PAPER
© Georg Thieme Verlag Stuttgart · New York
2-Amino-4-pyrrolidinothieno[2,3-d]pyrimidine-6-carboxylic Acid as an N-Terminal Surrogate in Amino Acid and Peptide Analogues
Further Information
Received
6 June 2005
Publication Date:
06 October 2005 (online)
Publication History
Publication Date:
06 October 2005 (online)
Abstract
2-Amino-4-pyrrolidinothieno[2,3-d]pyrimidine-6-carboxylic acid (4) (ATPC) is an unnatural amino acid with promise in applications as a building block for the synthesis of peptidomimetics. ATPC was obtained from both 3a and 3b thienopyrimidines by hydrolysis and hydrogenolysis, respectively. The synthesis of eleven ATPC-amino acids and two ATPC-peptides is described. ATPC is incorporated as N-terminal moiety in solution or solid-phase peptide synthesis using Boc or Fmoc methodology and without protection of the ATPC amino group.
Key words
heterocycles - amino acids - peptides - thienopyrimidine - angiotensin II
- 1
Matthew GB.Daniel HR. J. Med. Chem. 2002, 45: 541 -
2a In
Advances in Amino Acid Mimetics and Peptidomimetics
Vol. 1:
Abell A. JAI Press; Greenwich: 1997. -
2b In
Advances in Amino Acid Mimetics and Peptidomimetics
Vol. 2:
Abell A. JAI Press; Greenwich: 1999. -
3a
Methods in Molecular Medicine, Peptidomimetics Protocols
Vol. 30:
Kazmierski WM.Walker JM. Human Press; Totowa NJ: 1999. -
3b
Plant A.Stieber F.Scherkenbeck J.Lösel P.Dyker H. Org. Lett. 2001, 3: 3427 -
3c
Abell AD. Lett. Pept. Sci. 2002, 8: 267 -
3d
Lampariello LA.Piras D.Rodriquez M.Taddei M. J. Org. Chem. 2003, 68: 7893 - 4
Roth B. J. Med. Chem. 1969, 12: 227 -
5a
Varvounis G.Giannopoulos T. Adv. Heterocycl. Chem. 1996, 66: 193 -
5b
Eguchi J.Saitoh Y.Egawa M.Saito KI.Kawamura H. Pharmacol., Biochem. Behav. 1997, 56: 229 -
5c
Modica M.Santagati M.Russo F.Parotti L.Gioia L.Selvaggini C.Salmona M.Mennini T. J. Med. Chem. 1997, 40: 574 -
5d
Katada J.Iijima K.Muramatsu M.Takami M.Yasuda E.Hayashi M.Hattori M.Hayashi Y. Bioorg. Med. Chem. Lett. 1999, 9: 797 -
5e
Panico A.Cardile V.Santagati A.Gentile B. Farmaco 2001, 56: 959 -
5f
Sasaki S.Cho N.Nara Y.Harada M.Endo S.Suzuki N.Furuya S.Fujino M. J. Med. Chem. 2003, 46: 113 -
5g
Munchhof MJ.Beebe JS.Casavant JM.Cooper BA.Doty JL.Higdon RC.Hillerman SM.Soderstrom CI.Knauth EA.Marx MA.Rossi AMK.Sobolov SB.Sun J. Bioorg. Med. Chem. Lett. 2004, 14: 21 -
6a
Regoli D.Park WK.Rioux F. Pharmacol. Rev. 1974, 26: 69 -
6b
Khosla MC.Smeby RR.Bumpus FM. In Handbook of Experimental Pharmacology, AngiotensinPage IH.Bumpus FM. Springer Verlag; Berlin: 1974. -
6c
Hardman JG.Goodman Gilmon A.Limbird LE. In Goodman & Gilman’s The Pharmacological Basis of Therapeutics 9th ed.: McGraw-Hill Companies; New York: 1996. -
6d
Miura S.Feng Y.-H.Husain A.Karnik SS. J. Biol. Chem. 1999, 274: 7103 ; and refs therein - 7
Clark J.Korakas D.Shahhet MS.Varvounis G. J. Heterocycl. Chem. 1993, 30: 1065 -
8a
Cordopatis P.Manessi-Zoupa E.Bosse R.Bouley R.Gagnon S.Escher E. Int. J. Pept. Protein Res. 1994, 44: 320 -
8b
Cordopatis P.Theodoropoulos D.Escher E. In Bioactive Peptides in Drug Discovery and DesignMatsoukas J.Mavromoustakos T. IOS Press; Amsterdam: 1999. -
8c
Zalcberg H.Assimomytis N.Magafa V.Manessi-Zoupa E.Cordopatis P.Shimuta SI. J. Pept. Res. 1999, 53: 678 -
8d
Assimomytis N.Magafa V.Manessi-Zoupa E.Theodoropoulos D.Cordopatis P.Perodin J.Bouley R.Escher E. Arzneimittelforschung/Drug Res. 2000, 50: 526 - 9
Spyroulias GA.Nikolakopoulou P.Tzakos A.Gerothanassis IP.Magafa V.Manessi-Zoupa E.Cordopatis P. Eur. J. Biochem. 2003, 270: 2163 - 10
Mohamadi F.Richards NGJ.Guida WC.Liskamp R.Caufield C.Chang G.Hendrickson T.Still WC. J. Comput. Chem. 1990, 11: 440 - 11
Kolossvary I.Guida WC. J. Am. Chem. Soc. 1996, 118: 5011 - 12
Armarego WLF.Perrin DD. Purification of Laboratory Chemicals Butterworth-Heinemann; Oxford: 1996. - 13
Karagiannis K.Stavropoulos G.Poulos C.Jordan CC.Hagan RM. Int. J. Pept. Protein Res. 1993, 42: 565 - 14
Z-Leu-Glu(t-Bu)-NH2 was prepared in 93% yield; mp 139-140 °C, R
f
0.80 (BuOH-AcOH-H2O, 4:1:1); R
f
0.52 (MeCN-H2O, 7:1); t
R
= 25.95 min according to:
Baumeister B.Matile S. Chem. Eur. J. 2000, 6: 1739 - 15
Barlos K.Chatzi O.Gatos D.Stavropoulos G. Int. J. Pept. Protein Res. 1991, 37: 513 - 16
Bernatowitz MS.Daniels SB.Köster H. Tetrahedron Lett. 1989, 30: 4645 - 17
Kaiser E.Colescott RL.Bossinger CD.Cook PI. Anal. Biochem. 1970, 34: 595 - 18
Christensen T. Acta Chem. Scand., Ser. B 1979, 33: 763